The mammalian target of rapamycin (mTOR) inhibitors. a set of promising potential anti-cancer agents. has shown response variability among individuals. This study aimed to identify novel biomarkers and mechanisms that might influence the response to Rapamycin and Everolimus. https://foldlyers.shop/product-category/top-mount/